Found 301 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R et al..  2014.  Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.. Surgery. 156(6):1342-50;discussion1350.
Elkhader J, Elemento O.  2021.  Artificial intelligence in oncology: From bench to clinic.. Semin Cancer Biol.
Elemento O, Gascuel O.  2002.  An efficient and accurate distance based algorithm to reconstruct tandem duplication trees.. Bioinformatics. 18 Suppl 2:S92-9.
Elemento O.  2020.  The future of precision medicine: towards a more predictive personalized medicine.. Emerg Top Life Sci. 4(2):175-177.
Elemento O, Lefranc MPaule.  2003.  IMGT/PhyloGene: an on-line tool for comparative analysis of immunoglobulin and T cell receptor genes.. Dev Comp Immunol. 27(9):763-79.
Elemento O.  2007.  Developing a systems-level understanding of gene expression.. Genome Biol. 8(4):304.
Elemento O, Tavazoie S.  2005.  Fast and systematic genome-wide discovery of conserved regulatory elements using a non-alignment based approach.. Genome Biol. 6(2):R18.
Elemento O, Slonim N, Tavazoie S.  2007.  A universal framework for regulatory element discovery across all genomes and data types.. Mol Cell. 28(2):337-50.
Elemento O, Rubin MA, Rickman DS.  2012.  Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.. Cell Cycle. 11(18):3380-3.
Elemento O.  2016.  KLF4: A new player in plasma cell development.. Cell Cycle. 15(20):2691-2.
Elemento O, Tavazoie S.  2007.  Fastcompare: a nonalignment approach for genome-scale discovery of DNA and mRNA regulatory elements using network-level conservation.. Methods Mol Biol. 395:349-66.
Elemento O, Gascuel O, Lefranc M-P.  2002.  Reconstructing the duplication history of tandemly repeated genes.. Mol Biol Evol. 19(3):278-88.
Elemento O.  2021.  Towards artificial intelligence-driven pathology assessment for hematological malignancies.. Blood Cancer Discov. 2(3):195-197.
Elemento O.  2021.  The road from Rous sarcoma virus to precision medicine.. J Exp Med. 218(4)
Durrans A, Gao D, Gupta R, Fischer KR, Choi H, Rayes TEl, Ryu S, Nasar A, Spinelli CF, Andrews W et al..  2015.  Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.. PLoS One. 10(6):e0129123.
Du W, Goldstein R, Jiang Y, Aly O, Cerchietti L, Melnick A, Elemento O.  2017.  Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model.. Cancer Res. 77(8):1818-1830.
Dooley BJ, Verma A, Ding R, Yang H, Muthukumar T, Lubetzky M, Shankaranarayanan D, Elemento O, Suthanthiran M.  2020.  Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts.. Transplant Direct. 6(8):e588.
Dominguez PM, Teater M, Chambwe N, Kormaksson M, Redmond D, Ishii J, Vuong B, Chaudhuri J, Melnick A, Vasanthakumar A et al..  2015.  DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID.. Cell Rep. 12(12):2086-98.
Dominguez PM, Ghamlouch H, Rosikiewicz W, Kumar P, Béguelin W, Fontán L, Rivas MA, Pawlikowska P, Armand M, Mouly E et al..  2018.  TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.. Cancer Discov. 8(12):1632-1653.
Doane AS, Elemento O.  2017.  Regulatory elements in molecular networks.. Wiley Interdiscip Rev Syst Biol Med. 9(3)
Dixon G, Pan H, Yang D, Rosen BP, Jashari T, Verma N, Pulecio J, Caspi I, Lee K, Stransky S et al..  2021.  QSER1 protects DNA methylation valleys from de novo methylation.. Science. 372(6538)
Diman NYS-G, Brooks G, Kruithof BPT, Elemento O, Seidman JG, Seidman CE, Basson CT, Hatcher CJ.  2014.  Tbx5 is required for avian and Mammalian epicardial formation and coronary vasculogenesis.. Circ Res. 115(10):834-44.
Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JYun Helen, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N et al..  2012.  Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.. Proc Natl Acad Sci U S A. 109(17):6686-91.